Difficulties and Countermeasures of Prescription Indication Reviews of Chinese Patent Medicines / 医药导报
Herald of Medicine
; (12): 390-393, 2024.
Article
en Zh
| WPRIM
| ID: wpr-1023725
Biblioteca responsable:
WPRO
ABSTRACT
Prescription indication reviews are the problematic points in reviewing prescriptions of Chinese patent medi-cines.However,there is no commonly recognized review standard.This article conducted a statistical analysis of the prescriptions reviewed by pharmacists from July to December 2022 in the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine.Combined with work experience,we analyzed the results and reasons for unqualified indication reviews,combed out the difficulties of the indications review in Chinese patent medicines,and proposed feasible strategies to provide support for the stand-ardization and standardized development in reviewing prescriptions of Chinese patent medicines.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Herald of Medicine
Año:
2024
Tipo del documento:
Article